NCT02818569View on ClinicalTrials.gov

Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
SleepInsomnia
Interventions
DRUG

Dexmedetomidine

Oral form

OTHER

Saline Placebo

Saline Placebo

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02818569 - Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic | Biotech Hunter | Biotech Hunter